Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
Hospitalized patients with severe COVID-19 have an increased incidence of insulin resistance, impaired beta cell function, glucose intolerance (prediabetes), and overt type 2 diabetes (T2D) compared to non-hospitalized patients with COVID-19 and COVID-19 negative individuals on long-term follow up.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
View:
• Body Mass index (BMI) \< 40 kg/m2
Locations
United States
Texas
Texas Diabetes Institute - University Health System
RECRUITING
San Antonio
Contact Information
Primary
Marzieh Salehi, MD
salehi@uthscsa.edu
(210) 567-6691
Backup
Andrea Hansis Diarte, MPH
hansisdiarte@uthscsa.edu
210-567-3208
Time Frame
Start Date: 2023-07-10
Estimated Completion Date: 2026-08
Participants
Target number of participants: 213
Treatments
Severe COVID-19 Group
Hospitalized in ICU with COVID-19 (PCR positive) and recovered
Mild COVID-19 positive Group
COVID-19 positive (by PCR) who recovered from mild COVID-19 and were seen in outpatient clinics or ER with symptoms that did not justify hospitalization.
COVID-19 negative Group
COVID-19 negative (by PCR) and seen in outpatient clinics or ER during same time period as Groups I and II.
Related Therapeutic Areas
Sponsors
Leads: The University of Texas Health Science Center at San Antonio
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)